COVID-19 Outcomes in Hospitalized Patients With Neurodegenerative Disease
A Retrospective Cohort Study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 31, 2020
- Accepted June 30, 2021
- First Published July 16, 2021.
Article Versions
- Previous version (July 16, 2021 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Roshni Abee Patel, MD,
- Glenn T. Stebbins, PhD (glenn_stebbins{at}rush.edu),
- Ekta B. Kishen, MPH (ekta_b_kishen{at}rush.edu) and
- Brandon Barton, MD, MS (brandon_r_barton{at}rush.edu)
- Roshni Abee Patel, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Glenn T. Stebbins, PhD (glenn_stebbins{at}rush.edu),
1. Ultragenyx Pharmaceutical 2. Medgenesis 3. Cleveland Clinic Foundation
NONE
1. International Parkinson and Movement Disorder Society - Travel 2. Dystonia Coalition - Travel 3. American Academy of Neurology - Honoraria 4. Michael J. Fox Foundation for Parkinson's Research - Honoraria 5. Food and Drug Administration - Honoraria 6. National Institutes of Health - Honoraria 7. TOXINS - Travel 8. American Society for Experimental Neurotherapeutics - Travel
NONE
NONE
NONE
NONE
1. Acadia Pharmaceuticals 2. Adamas Pharmaceuticals, Inc. 3. Ceregene, Inc. 4. CHDI Management, Inc. 5. Ingenix Pharmaceutical Services (i3 Research) 6. Neurocrine Biosciences, Inc. 7. Pfizer, Inc. 8. Tool-4-Patient
NONE
NONE
NONE
NONE
1. US Army Medical Research and Materiel Command, PR161108, Co-I, 2017- 2022
NONE
1. Michael J. Fox Foundation for Parkinson's Research 2. CHDI 3. Dystonia Coalition 4. International Parkinson and Movement Disorder Society 5. CBD Solution
NONE
NONE
NONE
NONE
NONE
NONE
- Ekta B. Kishen, MPH (ekta_b_kishen{at}rush.edu) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brandon Barton, MD, MS (brandon_r_barton{at}rush.edu)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
honoraria from pharmaceutical companies for consultancy
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Department of Neurological Sciences (RAP, GTS, BB), Rush University Medical Center, Chicago, IL; Bioinformatics and Biostatistics Core (EBK), Rush University Medical Center, Chicago, IL; and Neurology Service (BB), Jesse Brown Veterans Affairs Medical Center, Chicago, IL.
- Correspondence
Dr. Patel roshnipatel1988{at}gmail.com
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.